Cancer Immune Therapy Edited by G. Stuhler and P. Walden ...

35 Heiser, A., Maurice, M. A.,Yancey,
D. R., Coleman, D. M., Dahm, P. and
Vieweg, J. Human dendritic cells transfected
with renal tumor RNA stimulate
polyclonal T-cell responses against antigens
expressed by primary and metastatic
tumors, Cancer Res 61: 3388±93,
2001.
36 Vonderheide, R., Anderson, K.,
Hahn,W., Butler, M., Schultze, J.
and Nadler, L. Characterization of
HLA-A3-restricted cytotoxic T lymphocytes
reactive against the widely expressed
tumor antigen telomerase, Clin
Cancer Res 61: 8366±8370, 2001.
37 Arai, J.,Yasukawa, M., Ohminami, H.,
Kakimoto, M., Hasegawa, A. and
Fujita, S. Identification of human
telomerase reverse transcriptasederived
peptides that induce HLA-A24restricted
antileukemia cytotoxic T
lymphocytes, Blood 97: 2903±7,
2001.
38 Hahn,W. C., Counter, C. M., Lundberg,
A. S., Beijersbergen, R. L.,
Brooks, M. W. and Weinberg, R. A.
Creation of human tumour cells with
defined genetic elements, Nature 400:
464±8, 1999.
39 Greenberg, R. A., Chin, L., Femino, A.,
Lee, K. H., Gottlieb, G. J., Singer, R.
H., Greider, C. W. and DePinho, R. A.
Short dysfunctional telomeres impair tumorigenesis
in the INK4a(delta2/3) cancer-prone
mouse, Cell 97: 515±25, 1999.
40 Hahn,W. C., Stewart, S. A., Brooks,
M. W.,York, S. G., Eaton, E., Kurachi,
A., Beijersbergen, R. L., Knoll, J. H.,
Meyerson, M. and Weinberg, R. A. Inhibition
of telomerase limits the growth
of human cancer cells, Nat Med 5:
1164±70, 1999.
41 Herbert, B., Pitts, A. E., Baker, S. I.,
Hamilton, S. E.,Wright,W. E., Shay,
J. W. and Corey, D. R. Inhibition of human
telomerase in immortal human
cells leads to progressive telomere
shortening and cell death, Proc Natl
Acad Sci USA. 96: 14276±81, 1999.
42 Jager, E., Ringhoffer, M., Karbach, J.,
Arand, M., Oesch, F. and Knuth, A.
Inverse relationship of melanocyte differentiation
antigen expression in melanoma
tissues and CD8 + cytotoxic-T-cell
References
responses: evidence for immunoselection
of antigen-loss variants in vivo, Int J
Cancer 66: 470±6, 1996.
43 Harle-Bachor, C. and Boukamp, P.
Telomerase activity in the regenerative
basal layer of the epidermis inhuman
skin and in immortal and carcinomaderived
skin keratinocytes, Proc Natl
Acad Sci USA 93: 6476±81, 1996.
44 Yasumoto, S., Kunimura, C., Kikuchi,
K., Tahara, H., Ohji, H., Yamamoto,
H., Ide, T. and Utakoji, T. Telomerase
activity in normal human
epithelial cells, Oncogene 13: 433±9,
1996.
45 Norrback, K. F. and Roos, G. Telomeres
and telomerase in normal and
malignant haematopoietic cells, Eur J
Cancer 33: 774±80, 1997.
46 Baltimore, D. Our genome unveiled,
Nature 409: 814±6, 2001.
47 Schmitz, M., Diestelkoetter, P., Weigle,
B., Schmachtenberg, F., Stevanovic,
S., Ockert, D., Rammensee, H.
G. and Rieber, E. P. Generation of survivin-specific
CD8 + Teffector cells by
dendritic cells pulsed with protein or
selected peptides, Cancer Res 60: 4845±
9, 2000.
48 van der Bruggen, P., Bastin, J., Gajewski,
T., Coulie, P. G., Boel, P., De
Smet, C., Traversari, C., Townsend, A.
and Boon, T. A peptide encoded by human
gene MAGE-3 and presented by
HLA-A2 induces cytolytic T lymphocytes
that recognize tumor cells expressing
MAGE-3, Eur JImmunol 24: 3038±
43, 1994.
49 Melief, C. J. and Kast,W. M. T-cell immunotherapy
of cancer, Res Immunol
142: 425±9, 1991.
50 Gedde-Dahl, T., III, Fossum, B., Eriksen,
J. A., Thorsby, E. and Gaudernack,
G. T cell clones specific for
p21 ras -derived peptides: characterization
of their fine specificity and HLA restriction,
Eur JImmunol 23: 754±60,
1993.
51 Chen,W., Peace, D. J., Rovira, D. K.,
You, S. G. and Cheever, M. A. T-cell
immunity to the joining region of
p210 BCR±ABL protein, Proc Natl Acad Sci
USA 89: 1468±72, 1992.
15